Brazilian guideline for screening and diagnosis of type 2 diabetes: a position statement from the Brazilian Diabetes Society

被引:0
作者
Rodacki, Melanie [1 ]
Zajdenverg, Lenita [1 ]
da Silva Jr, Wellington Santana [2 ]
Giacaglia, Luciano [3 ]
Negrato, Carlos Antonio [4 ]
Cobas, Roberta Arnoldi [5 ]
de Almeida-Pititto, Bianca [6 ]
Bertoluci, Marcello Casaccia [7 ]
机构
[1] Univ Fed Rio De Janeiro, Dept Clin Med Nutrol, Rio De Janeiro, Brazil
[2] Univ Fed Maranhao, Dept Med 1, Disciplina Endocrinol, Sao Luis, Brazil
[3] Univ Sao Paulo, Hosp Clin, Fac Med, Sao Paulo, Brazil
[4] Univ Sao Paulo, Fac Med Bauru, Bauru, Brazil
[5] Univ Estado Rio De Janeiro, Fac Ciencias Med, Dept Med Interna, Rio De Janeiro, Brazil
[6] Univ Fed Sao Paulo, Dept Med Prevent, Escola Paulista Med, Sao Paulo, Brazil
[7] Univ Fed Rio Grande do Sul, Serv Endocrinol Hosp Clin Porto Alegre, Fac Med, Porto Alegre, Brazil
关键词
Practice guidelines: type 2 diabetes mellitus; Prediabetic state; Blood glucose; Glycated hemoglobin; Oral glucose tolerance test; Diagnosis; Early diagnosis; Disease prevention; FASTING PLASMA-GLUCOSE; GLYCATED HEMOGLOBIN; CARDIOVASCULAR RISK; METABOLIC SYNDROME; OBESE CHILDREN; TOLERANCE TEST; LIFE-STYLE; FOLLOW-UP; OGTT; PREVALENCE;
D O I
10.1186/s13098-024-01572-w
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Patients with type 2 diabetes (T2D) often experience prolonged periods of asymptomatic hyperglycemia, which significantly increases the risk of developing chronic complications related to diabetes. Screening programs for individuals at high risk for T2D provide valuable opportunities not only for early diagnosis but also for detecting intermediate hyperglycemic states, commonly referred to as prediabetes. Interventions aimed at preventing diabetes in this group can successfully delay or even avoid the onset of the disease and its associated burdens. This review is an update of the Brazilian Diabetes Society (Sociedade Brasileira de Diabetes [SBD]) evidence-based guideline for diagnosing diabetes and screening T2D. Methods The methodology was previously published and defined by the internal institutional steering committee. The working group drafted the manuscript by selecting vital clinical questions for a narrative review, utilizing MEDLINE via PubMed to identify relevant studies. The review assessed the best available evidence, including randomized clinical trials (RCTs), meta-analyses, and high-quality observational studies related to the diagnosis of diabetes. Results and conclusions Fifteen specific recommendations were formulated. Screening is recommended for adults aged 35 and older or younger individuals with obesity and additional risk factors. For children and adolescents, screening is recommended starting at age ten or the onset of puberty if they are overweight or obese and have additional risk factors. Fasting plasma glucose (FPG) and HbA1c are recommended as initial screening tests. The oral glucose tolerance test (OGTT) is recommended for high-risk individuals with normal HbA1c and FPG or those with prediabetes. The 1-h OGTT is preferred over the 2-h OGTT, as it is both more practical and a superior test. A structured approach to reevaluation intervals is provided.
引用
收藏
页数:18
相关论文
共 50 条
  • [31] Screening for Type 2 Diabetes in Obese Youth
    Shah, Shuchi
    Kublaoui, Bassil M.
    Oden, Jon D.
    White, Perrin C.
    PEDIATRICS, 2009, 124 (02) : 573 - 579
  • [32] Recommendations on screening for type 2 diabetes in adults
    Pottie, Kevin
    Jaramillo, Alejandra
    Lewin, Gabriela
    Dickinson, Jim
    Bell, Neil
    Brauer, Paula
    Dunfield, Lesley
    Joffres, Michel
    Singh, Harminder
    Tonelli, Marcello
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2012, 184 (15) : 1687 - 1696
  • [33] Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement
    Negrato, Carlos Antonio
    Montenegro, Renan M., Jr.
    Mattar, Rosiane
    Zajdenverg, Lenita
    Francisco, Rossana P. V.
    Pereira, Belmiro Goncalves
    Sancovski, Mauro
    Torloni, Maria Regina
    Dib, Sergio A.
    Viggiano, Celeste E.
    Golbert, Airton
    Moises, Elaine C. D.
    Favaro, Maria Isabel
    Calderon, Iracema M. P.
    Fusaro, Sonia
    Piliakas, Valeria D. D.
    Dias, Jose Petronio L.
    Gomes, Marilia B.
    Jovanovic, Lois
    DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
  • [34] The Costs of Type 2 Diabetes Mellitus Outpatient Care in the Brazilian Public Health System
    Bahia, Luciana R.
    Araujo, Denizar Vianna
    Schaan, Beatriz D.
    Dib, Sergio A.
    Negrato, Carlos Antonio
    Leao, Marluce P. S.
    Ramos, Alberto Jose S.
    Forti, Adriana C.
    Gomes, Marilia B.
    Foss, Maria Cristina
    Monteiro, Rosane A.
    Sartorelli, Daniela
    Franco, Laercio J.
    VALUE IN HEALTH, 2011, 14 (05) : S137 - S140
  • [35] Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM)
    Martins, Joao Roberto M.
    Villagelin, Danilo G. P.
    Carvalho, Gisah A.
    Vaisman, Fernanda
    Teixeira, Patricia F. S.
    Scheffel, Rafael S.
    Sgarbi, Jose A.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2021, 65 (03): : 368 - 375
  • [36] Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology
    Seferovic, Peter
    Farmakis, Dimitrios
    Bayes-Genis, Antoni
    Ben Gal, Tuvia
    Bohm, Michael
    Chioncel, Ovidiu
    Ferrari, Roberto
    Filippatos, Gerasimos
    Hill, Loreena
    Jankowska, Ewa
    Lainscak, Mitja
    Lopatin, Yuri
    Lund, Lars H.
    Mebazaa, Alexandre
    Metra, Marco
    Moura, Brenda
    Rosano, Giuseppe
    Thum, Thomas
    Voors, Adriaan
    Coats, Andrew J. S.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 (07) : 1162 - 1170
  • [37] Tools for Practice Screening and diagnosis of type 2 diabetes with HbA1c
    Mannarino, Marco
    Tonelli, Marcello
    Allan, G. Michael
    CANADIAN FAMILY PHYSICIAN, 2013, 59 (01) : 42 - 42
  • [38] Comparison of venous plasma glycemia and capillary glycemia for the screening of type 2 diabetes mellitus in the Japanese-Brazilian community of Mombuca (Guatapara-SP)
    Foss-Freitas, Maria Cristina
    de Andrade, Regina C. G.
    Figueiredo, Roberta C.
    Pace, Ana Emilia
    Martinez, Edson Z.
    Dal Fabro, Amaury L.
    Franco, Laercio J.
    Foss, Milton C.
    DIABETOLOGY & METABOLIC SYNDROME, 2010, 2
  • [39] Iranian Endocrine Society Guidelines for Screening, Diagnosis, and Management of Gestational Diabetes Mellitus
    Valizadeh, Majid
    Hosseinpanah, Farhad
    Tehrani, Fahimeh Ramezani
    Abdi, Hengameh
    Mehran, Ladan
    Hadaegh, Farzad
    Amouzegar, Atieh
    Sarvghadi, Farzaneh
    Azizi, Fereidoun
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2021, 19 (01)
  • [40] Screening for Type 1 and Type 2 Diabetes
    Ekoe, Jean-Marie
    Punthakee, Zubin
    Ransom, Thomas
    Prebtani, Ally P. H.
    Goldenberg, Ronald
    CANADIAN JOURNAL OF DIABETES, 2013, 37 : S12 - S15